Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by Rituximab
Open Access
- 23 June 2003
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 32 (1), 57-63
- https://doi.org/10.1038/sj.bmt.1704102
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphomaBlood, 2002
- Molecular cytogenetic characterization of non‐Hodgkin lymphoma cell linesGenes, Chromosomes and Cancer, 2001
- Quantitative detection of t(14;18)-positive cells in patients with follicular lymphoma before and after autologous bone marrow transplantationBone Marrow Transplantation, 2000
- Long-Term Follow-Up of Autologous Bone Marrow Transplantation in Patients With Relapsed Follicular LymphomaBlood, 1999
- High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell LymphomaNew England Journal of Medicine, 1997
- Product Differentiation by Analysis of DNA Melting Curves during the Polymerase Chain ReactionAnalytical Biochemistry, 1997
- Molecular Monitoring of Minimal Residual Disease in Follicular and Mantle Cell Non-Hodgkin's Lymphomas Treated With High-Dose Chemotherapy and Peripheral Blood Progenitor Cell AutograftingBlood, 1997
- Detection of minimal residual disease by polymerase chain reaction in b cell malignanciesThe International Journal of Cell Cloning, 1995
- All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatmentBlood, 1991
- Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18.Proceedings of the National Academy of Sciences, 1985